June 16, 2022: Osceola’s Pharma Platform Announces Eighth Acquisition
Plus, Blackford exits a construction equipment business, and HGGC raises $2.54 billion for its latest fund
Read the top headlines from Thursday, June 16, 2022 below:
Blackford Exits Construction Equipment Business
Lower middle-market private equity firm Blackford Capital announced its successful exit of Grand Equipment Company, an equipment dealer across a wide range of heavy construction equipment. The business was acquired by Cognitive Capital Partners, based in Chicago. Blackford acquired Grand Equipment Company in 2015 and subsequently supported the company’s growth efforts by investing in its management team, expanding the mix of equipment the business offers, growing its fleet of rental equipment, strengthening customer relationships and more. Blackford noted in its announcement that the construction industry is expected to grow 8.8% this year.
HGGC Lands $2.54 Billion for Latest Fund
Middle-market private equity firm HGGC said in a press release it completed a fundraising round for HGGC Fund IV, securing $2.54 billion in capital commitments. The raise exceeded the firm’s initial target of $2.25 billion, the announcement noted, and included a significant commitment from the firm’s General Partner, its largest investor across all of the firm’s funds. Fund IV has already invested in nine platform investments, HGGC said, including investments in Aspire Holdings, Grant Fitness, PCF Insurance and more. The fund is focused on business and tech-enabled services, consumer, financial services, and software and technology.
Osceola’s Revelation Pharma Announces Eighth Acquisition
Lower middle-market private equity firm Osceola Capital said in a press release that its Revelation Pharma Corporation platform company has made its eighth acquisition in Wedgewood Pharmacy, which operates pharmacies offering medication for animal patients across the U.S. Financial terms of the acquisition were not revealed. In Osceola’s announcement, the firm noted an increasing number of pharmacy collaborations ahead as pharmacies struggle to navigate increasingly complex regulations while meeting the healthcare needs of patient.
Related content: Beyond Industry Expertise: Why Buyers Should Explore Less Familiar, but Adjacent, Markets
